Debt-to-equity of RenovoRx, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
RenovoRx, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • RenovoRx, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 35%, a 60% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

RenovoRx, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 35% -52% -60% 30 Sep 2025
Q2 2025 35% -135% -79% 30 Jun 2025
Q1 2025 36% +41385% 31 Mar 2025
Q4 2024 55% -939% -94% 31 Dec 2024
Q3 2024 87% -17% -16% 30 Sep 2024
Q2 2024 171% +125% +271% 30 Jun 2024
Q1 2024 -41349% -41365% -247255% 31 Mar 2024
Q4 2023 994% +981% +7663% 31 Dec 2023
Q3 2023 104% +94% +951% 30 Sep 2023
Q2 2023 46% +39% +525% 30 Jun 2023
Q1 2023 17% 31 Mar 2023
Q4 2022 13% 31 Dec 2022
Q3 2022 10% 30 Sep 2022
Q2 2022 7% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.